Cellectis (CLLS) EBT Margin Growth (5y) (2020 - 2026)
Cellectis (CLLS) EBT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,368.00 |
| Dec 31, 2025 | -45,618.00 |
| Sep 30, 2025 | 55,327.00 |
| Jun 30, 2025 | 130,349.00 |
| Mar 31, 2025 | -505.00 |
| Dec 31, 2024 | 49,266.00 |
| Sep 30, 2024 | 38,157.00 |
| Jun 30, 2024 | 333,021.00 |
| Mar 31, 2024 | 268,455.00 |
| Dec 31, 2023 | -2.82 Mn |
| Sep 30, 2023 | -2.17 Mn |
| Jun 30, 2023 | -1.92 Mn |
| Mar 31, 2023 | -1.22 Mn |
| Dec 31, 2022 | 63,737.00 |
| Sep 30, 2022 | -1.29 Mn |
| Jun 30, 2022 | -87,814.00 |
| Mar 31, 2022 | -4,749.00 |
| Dec 31, 2021 | -879.00 |
| Sep 30, 2021 | -41,806.00 |
| Jun 30, 2021 | -26,494.00 |